News and Trends 18 Jul 2019
Genmab’s Huge IPO Raises €450M to Develop Antibody Drugs
The Danish biotech Genmab has made a big splash on the Nasdaq, raising a €450M ($506M) IPO to fuel its antibody drug programs in cancer, autoimmune diseases, and more. This…